124 results
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
7:00am
of shares of Common Stock issued and outstanding. For purposes of this definition, “consultant” means a consultant that may participate in an “employee
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
) where such failure to file or pay would not have a Company Material Adverse Effect.
(l) Employee Relations. No labor problem or dispute … , employees, employee benefit plans, conditions or prospects, and the Company hereby disclaims any such other representations or warranties. In particular
424B5
RYTM
Rhythm Pharmaceuticals Inc.
29 Feb 24
Prospectus supplement for primary offering
4:44pm
reserved for future issuance under our 2017 Employee Stock Purchase Plan; and
179,925 shares of common stock reserved for future issuance under our 2022 … officers and (2) shares owned under employee stock plans in which employee participants do not have the right to determine confidentially whether
8-K
EX-3.1
as3k 16iob
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
EX-10.1
25qczlimyql5dyc
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.2
xwaru1z2
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.4
5qqkwx
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.3
zx7c8oie
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-1.1
tqyj 2uhc7r
15 Sep 22
Other Events
4:02pm
424B5
6u8z j66jzd8lzi
15 Sep 22
Prospectus supplement for primary offering
4:00pm